Benjamin S B Rasmussen1, Knud B Yderstraede2, Bendix Carstensen3, Ole Skov4, Henning Beck-Nielsen2. 1. Department of Medical Endocrinology, Odense University Hospital Denmark, Sdr. Boulevard 29, 5000, Odense C, Denmark. bsr@rsyd.dk. 2. Department of Medical Endocrinology, Odense University Hospital Denmark, Sdr. Boulevard 29, 5000, Odense C, Denmark. 3. Clinical Epidemiology, Steno Diabetes Centre, Gentofte, Denmark. 4. Department of Orthopaedic Surgery, Odense University Hospital, Odense, Denmark.
Abstract
AIMS/HYPOTHESIS: The aim of this study was to describe the trends in rates of amputation among individuals with and without diabetes. METHODS: We studied amputation rates in the County of Funen (approximately 0.5 million residents) during the period 1996-2011. Amputations were identified from the hospital administrative system, diabetes status by linkage with the Danish National Diabetes Register, and mortality and population data by extraction from Statistics Denmark. Amputation rates were analysed using proportional hazard models. We analysed the incidence of the first amputation at each level as well as the incidence of further amputations, subdivided by level of amputation. RESULTS: During the period 1996-2011, a total of 2,832 amputations were performed, of which 1,285 were among patients with diabetes and 1,547 among individuals without diabetes. Relative to persons without diabetes, patients with diabetes had an HR for below-ankle amputations (BAAs) of 14.7 for men and 7.5 for women, and for from-ankle-to-knee amputations (BKAs) of 7.6 and 8.4 for men and women, respectively. For above-knee amputations (AKAs) the numbers were 4.0 for men and 3.7 for women. We found an annual reduction in BAA rates among patients with diabetes of 9.8%, and the annual reduction in BKA for patients with diabetes was 15.1%. CONCLUSIONS/ INTERPRETATION: The amputation rate in patients with diabetes is still several-fold higher than in persons without diabetes, but the improvements in diabetes care in recent years have resulted in a steady decline in amputation rates among patients with diabetes from this Danish cohort.
AIMS/HYPOTHESIS: The aim of this study was to describe the trends in rates of amputation among individuals with and without diabetes. METHODS: We studied amputation rates in the County of Funen (approximately 0.5 million residents) during the period 1996-2011. Amputations were identified from the hospital administrative system, diabetes status by linkage with the Danish National Diabetes Register, and mortality and population data by extraction from Statistics Denmark. Amputation rates were analysed using proportional hazard models. We analysed the incidence of the first amputation at each level as well as the incidence of further amputations, subdivided by level of amputation. RESULTS: During the period 1996-2011, a total of 2,832 amputations were performed, of which 1,285 were among patients with diabetes and 1,547 among individuals without diabetes. Relative to persons without diabetes, patients with diabetes had an HR for below-ankle amputations (BAAs) of 14.7 for men and 7.5 for women, and for from-ankle-to-knee amputations (BKAs) of 7.6 and 8.4 for men and women, respectively. For above-knee amputations (AKAs) the numbers were 4.0 for men and 3.7 for women. We found an annual reduction in BAA rates among patients with diabetes of 9.8%, and the annual reduction in BKA for patients with diabetes was 15.1%. CONCLUSIONS/ INTERPRETATION: The amputation rate in patients with diabetes is still several-fold higher than in persons without diabetes, but the improvements in diabetes care in recent years have resulted in a steady decline in amputation rates among patients with diabetes from this Danish cohort.
Authors: David G Armstrong; Manish Bharara; Matthew White; Brian Lepow; Sugam Bhatnagar; Timothy Fisher; Heather R Kimbriel; Jodi Walters; Kaoru R Goshima; John Hughes; Joseph L Mills Journal: Diabetes Metab Res Rev Date: 2012-09 Impact factor: 4.876
Authors: Gregory G Westin; Ehrin J Armstrong; Heejung Bang; Khung-Keong Yeo; David Anderson; David L Dawson; William C Pevec; Ezra A Amsterdam; John R Laird Journal: J Am Coll Cardiol Date: 2013-12-04 Impact factor: 24.094
Authors: Mohamad A Hussain; Mohammed Al-Omran; Konrad Salata; Atul Sivaswamy; Thomas L Forbes; Naveed Sattar; Badr Aljabri; Ahmed Kayssi; Subodh Verma; Charles de Mestral Journal: CMAJ Date: 2019-09-03 Impact factor: 8.262
Authors: Kamel Mohammedi; Mark Woodward; Yoichiro Hirakawa; Sophia Zoungas; Stephen Colagiuri; Pavel Hamet; Stephen Harrap; Neil Poulter; David R Matthews; Michel Marre; John Chalmers Journal: Cardiovasc Diabetol Date: 2016-09-02 Impact factor: 9.951
Authors: Maria Narres; Tatjana Kvitkina; Heiner Claessen; Sigrid Droste; Björn Schuster; Stephan Morbach; Gerhard Rümenapf; Kristien Van Acker; Andrea Icks Journal: PLoS One Date: 2017-08-28 Impact factor: 3.240
Authors: Meghan B Brennan; Glenn O Allen; Patrick D Ferguson; Joseph A McBride; Christopher J Crnich; Maureen A Smith Journal: Open Forum Infect Dis Date: 2017-02-20 Impact factor: 3.835
Authors: Ronit Calderon-Margalit; Michal Cohen-Dadi; Dana Opas; Dena H Jaffe; Jacob Levine; Arie Ben-Yehuda; Ora Paltiel; Orly Manor Journal: Isr J Health Policy Res Date: 2018-01-17
Authors: Heiner Claessen; Maria Narres; Burkhard Haastert; Werner Arend; Falk Hoffmann; Stephan Morbach; Gerhard Rümenapf; Tatjana Kvitkina; Heiko Friedel; Christian Günster; Ingrid Schubert; Walter Ullrich; Benjamin Westerhoff; Adrian Wilk; Andrea Icks Journal: Clin Epidemiol Date: 2018-04-20 Impact factor: 4.790
Authors: Heiner Claessen; Herve Avalosse; Joeri Guillaume; Maria Narres; Tatjana Kvitkina; Werner Arend; Stephan Morbach; Patrick Lauwers; Frank Nobels; Jacques Boly; Chris Van Hul; Kris Doggen; Isabelle Dumont; Patricia Felix; Kristien Van Acker; Andrea Icks Journal: Diabetologia Date: 2018-06-16 Impact factor: 10.122